We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+16.3%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$36.7B
AUM Growth
+$4.73B
Cap. Flow
+$3.45B
Cap. Flow %
9.42%
Top 10 Hldgs %
15.54%
Holding
3,403
New
385
Increased
1,787
Reduced
944
Closed
189

Sector Composition

Rank Sector Weight
1 Healthcare 9.66%
2 Technology 9.09%
3 Financials 7.96%
4 Consumer Staples 7.25%
5 Industrials 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXII
3176
DELISTED
GALENA BIOPHARMA INC COM
RXII
$4K ﹤0.01%
10,500
MEMP
3177
CALL
DELISTED
Memorial Production Partners LP Common Units
MEMP
$4K ﹤0.01%
10,900
EXC icon
3178
CALL
Exelon
EXC
$47B
$3K ﹤0.01%
39,116
-74,446
-66% -$1.87M
RF icon
3179
CALL
Regions Financial
RF
$26.8B
$3K ﹤0.01%
+16,600
New +$155K
GCVRZ
3180
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3K ﹤0.01%
11,349
-35
-0.3% -$9
NLY icon
3181
CALL
Annaly Capital Management
NLY
$17.4B
$2K ﹤0.01%
+3,175
New +$138K
OVV icon
3182
CALL
Ovintiv
OVV
$16.4B
$2K ﹤0.01%
2,680
-400
-13% -$17.9K
SLV icon
3183
CALL
iShares Silver Trust
SLV
$30.9B
$2K ﹤0.01%
32,600
+2,000
+7% +$37.2K
TSCO icon
3184
CALL
Tractor Supply
TSCO
$18B
$2K ﹤0.01%
+182,000
New +$3.03M
XLE icon
3185
CALL
State Street Energy Select Sector SPDR ETF
XLE
$37.6B
$2K ﹤0.01%
21,800
-200
-0.9% -$6.85K
BAC.WS.B
3186
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$2K ﹤0.01%
18,300
+6,000
+49% +$561
POT
3187
CALL
DELISTED
Potash Corp Of Saskatchewan
POT
$2K ﹤0.01%
+10,800
New +$178K
FRO icon
3188
CALL
Frontline
FRO
$8.85B
$1K ﹤0.01%
+11,700
New +$90.4K
LUMN icon
3189
CALL
Lumen
LUMN
$6.44B
$1K ﹤0.01%
22,800
SVRA icon
3190
Savara
SVRA
$1.19B
$1K ﹤0.01%
173
-21
-11% -$596
UPS icon
3191
CALL
United Parcel Service
UPS
$88.9B
$1K ﹤0.01%
+28,000
New +$3.06M
CYHHZ
3192
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$1K ﹤0.01%
35,880
ESRX
3193
CALL
DELISTED
Express Scripts Holding Company
ESRX
$1K ﹤0.01%
11,900
+1,200
+11% +$89.7K
KMI.WS
3194
DELISTED
Kinder Morgan Inc
KMI.WS
$1K ﹤0.01%
88,069
+64,920
+280% +$1.45K
DSKX
3195
DELISTED
DS HEALTHCARE GROUP, INC. NEW COMMON STOCK
DSKX
$1K ﹤0.01%
47,976
AA icon
3196
CALL
Alcoa
AA
$13.2B
-6,284
Closed -$1K
ADMA icon
3197
ADMA Biologics
ADMA
$2.22B
-10,891
Closed -$65K
AEHL icon
3198
Antelope Enterprise Holdings
AEHL
$1.07M
-2
Closed -$25K
AGO icon
3199
Assured Guaranty
AGO
$3.34B
-8,288
Closed -$210K
ALNY icon
3200
Alnylam Pharmaceuticals
ALNY
$29.3B
-4,008
Closed -$222K

Similar funds

Raymond James & Associates's Q3 2016 Portfolio in Review

As of Q3 2016, Raymond James & Associates held 3,403 positions worth $36.7B, up 15% from $31.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $3.45B of net new capital in Q3 2016, opening 385 new positions and adding to 1,787 existing holdings. Its largest new stake was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, up from 9.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was TotalEnergies, an estimated $614M trimmed.

  • Raymond James & Associates's largest Q3 2016 buy was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2016, an estimated $196M increase.
  • Raymond James & Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $614M.
  • Raymond James & Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $61.1M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $36.7B portfolio in Q3 2016.
  • Raymond James & Associates opened 385 new positions and closed 189 in Q3 2016.
  • Raymond James & Associates's portfolio value rose 15% quarter-over-quarter to $36.7B.

Based on Raymond James & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.